Citations

Showing 10 of 108104 citations.

Prognostication using molecular (mol) markers and clinicopathological (clpath) features in high-risk stage II/III colon cancer (CC).
Dienstmann, Rodrigo , Phipps, Amanda I. , Delorenzi, Mauro , Jessup, J. Milburn , Tejpar, Sabine , Sinicrope, Frank A. , Bot, Brian M. , Friend, Stephen , Newcomb, Polly A. , Sargent, Daniel J. , Guinney, Justin

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 3519-3519

10.1200/jco.2016.34.15_suppl.3519 Get It

Single-agent LV305 to induce anti-tumor immune and clinical responses in patients with advanced or metastatic sarcoma and other cancers expressing NY-ESO-1.
Somaiah, Neeta , Block, Matthew S. , Tu, Khanh, Hwu, Patrick , Jones, Robin L. , Gnjatic, Sacha , Lu, Hailing , Meulen, Jan ter , Hsu, Frank J., Gnjatic, Sacha , Jones, Robin L , Kim, Joseph W. , Shapiro, Geoffrey I. , Eder, Joseph P. , Pollack, Seth M.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 3093-3093

10.1200/jco.2016.34.15_suppl.3093 Get It

A phase 1b/2 study combining MM-151 + nal-IRI + 5-FU + leucovorin in RAS-wildtype metastatic colorectal cancer (mCRC).
Chan, Emily , Harb, Wael A., Mody, Kabir , Jiang, Xiaoy, McClure, Ty, Valencia, A. Gonzalez, Fitzgerald, Jonathan B., Pipas, J. Marc , Nering, Rachel, Kearns, Jeffrey D. , Lewis, Lionel D.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: TPS3633-TPS3633

10.1200/jco.2016.34.15_suppl.tps3633 Get It

Mutation analysis in metastatic colorectal cancers (mCRC) subjected to gene panel testing for BRAF and KRAS genes in clinical practice.
Foster, Nathan R. , Kipp, Benjamin R. , Voss, Jesse S. , Jones, Jeremy C , Sinicrope, Frank A.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e15049-e15049

10.1200/jco.2016.34.15_suppl.e15049 Get It

Intergroup randomized phase III study of postoperative oxaliplatin, 5-fluorouracil and leucovorin (mFOLFOX6) vs mFOLFOX6 and bevacizumab (Bev) for patients (pts) with stage II/ III rectal cancer receiving pre-operative chemoradiation.
Benson, Al B. , Meropol, Neal J. , Catalano, Paul J. , Chakravarthy, Bapsi, Flynn, Patrick J. , Catalano, Robert B., Giantonio, Bruce J. , Mitchell, Edith P. , Haller, Daniel G. , Leichman, Cynthia G., Petrelli, Nicholas J. , Tepper, Joel E. , Brierley, James D. , Sigurdson, Elin R., Whittington, Richard M., O’Dwyer, Peter J. , Chakravarthy, A. Bapsi , Zhao, Fengmin , Sinicrope, Frank A. , Whittington, Richard M.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 3616-3616

10.1200/jco.2016.34.15_suppl.3616 Get It

Biomarkers of immune checkpoint inhibitor response in metastatic breast cancer: PD-L1 protein expression, CD274 gene amplification, and total mutational burden.
Gay, Laurie M. , Sheehan, Christine E., Dalvi, Siddhartha , Voronel, Olga, Elvin, Julia A. , Suh, James , Vergilio, Jo‐Anne, Fabrizio, David , Chumsri, Saranya , Ali, Siraj M. , Miller, Vincent A. , Stephens, Philip J., Ross, Jeffrey S , Elvin, Julia A , Frampton, Garrett M. , Chalmers, Zachary Rockow

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 3057-3057

10.1200/jco.2016.34.15_suppl.3057 Get It

Pharmacokinetic (PK)-driven individualization of pazopanib therapy in patients with solid tumors: A phase 1 study (MC1112).
Bible, Keith C. , Harris, Pamela Jo , Burton, Jill K., Yin, Jun , Qin, Rui , Satele, Daniel , Erlichman, Charles , Ramanathan, Ramesh K., Haluska, Paul

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 2577-2577

10.1200/jco.2016.34.15_suppl.2577 Get It

Phase 1, open-label, dose-escalation and expansion study of ABT-165, a dual variable domain immunoglobulin (DVD-Ig) targeting both DLL4 and VEGF, in patients (pts) with advanced solid tumors.
Ramanathan, Ramesh K., Wang, Lan , Fan, Xiaolin , Motwani, Monica, Wong, Shekman, Morgan-Lappe, Susan E. , Iyer, Suhasini , Naumovski, Louie, Gordon, Michael S. , Nemunaitis, John , Sledge, George W. , Strickler, John H.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 2507-2507

10.1200/jco.2016.34.15_suppl.2507 Get It

Phase I/II study of VAL-083 in patients with recurrent glioblastoma.
Shih, Kent C. , Patel, Manish R. , Butowski, Nicholas , Kizilbash, Sani H. , Bacha, Jeffrey , Brown, Dennis , Steinø, Anne, Schwartz, Richard S. , Kanekal, Sarath, Lopez, Lorena, Burris, Howard A. , Kizilbash, Sani H , Falchook, Gerald Steven

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 2063-2063

10.1200/jco.2016.34.15_suppl.2063 Get It

Validating RNAseq-signatures of vorinostat (VOR) sensitivity and resistance in patients with newly diagnosed glioblastoma (GBM) treated with VOR, temozolomide and radiation therapy in Alliance N0874/ABTC-0902.
Anderson, S. Keith , Jaeckle, Kurt A. , Buckner, Jan C. , Moore, Dennis F., Schiff, David , Ahluwalia, Manmeet S. , Lee, Eudocia Q. , Horvath, Laura E., Gerstner, Elizabeth R. , Lesser, Glenn J. , Prados, Michael D. , Wen, Patrick Y. , Ahluwalia, Manmeet S , Miller, C. Ryan , Sarkaria, Jann N. , Ligon, Keith L , Ballman, Karla V. , Grossman, Stuart A. , Giannini, Caterina , Wen, Patrick Yung , Galanis, Evanthia

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 2029-2029

10.1200/jco.2016.34.15_suppl.2029 Get It